Keeping Up with the Neighbors Speeds Vaccine Use

Researchers at the Johns Hopkins Bloomberg School of Public Health conducted an analysis of worldwide use of Haemophilus influenza Type b vaccine (Hib) to determine what factors influenced a nation’s adoption of the vaccine.

– Johns Hopkins Bloomberg School of Public Health|3/15/2010 1:00 PM EDT

Proton-Pump Inhibitor Plus Clopidogrel Is Less Likely to Cause Bleeding Ulcers

Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel – a drug that prevents blood clots – were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone.

– Agency for Healthcare Research and Quality (AHRQ)|3/15/2010 12:00 PM EDT

Generic Drug for Type 2 Diabetes Passes Next Clinical Hurdle

ShoelsonGoldfine.jpg

Salsalate, an anti-inflammatory agent, shows encouraging results in preliminary trial led by Joslin Diabetes Center.

– Joslin Diabetes Center|3/9/2010 4:00 PM EST

Urged on by Urchins: How Sea Lilies Got Their Get-Up-and-Go

Nature abounds with examples of evolutionary arms races. Certain marine snails, for example, evolved thick shells and spines to avoid be eaten, but crabs and fish foiled the snails by developing shell-crushing claws and jaws.

– University of Michigan|3/15/2010 4:45 PM EDT

U-M Researchers Solve a Molecular Mystery in Muscle

The muscle-building abilities of hormones known as insulin-like growth factors (IGFs) are legendary. Just do an online search and you'll find not only scientific papers discussing the effects of IGFs on the cells that give rise to muscle tissue, but also scores of ads touting the purported benefits of IGF supplements for bodybuilding.

– University of Michigan|3/15/2010 4:00 PM EDT

Stellar McGill Researcher Receives Killam Research Fellowship

McGill University is pleased to announce that the Canada Council for the Arts has awarded a Killam Research Fellowship to Dr. Victoria Kaspi for her astrophysics research.

– McGill University|3/15/2010 4:00 PM EDT

UVA First U.S. Hospital to Offer New Gamma Knife Technology for Cancers of the Head and Neck

UVA is offering the latest and most advanced technology in stereotactic radiosurgery, called Gamma Knife eXtend™, which allows physicians to treat larger tumors, multiple tumors and tumors near sensitive structures like the brainstem, facial nerves or the optic nerve.

– University of Virginia Health System|3/15/2010 4:00 PM EDT

Newswise provides quality news for journalists, media professionals, and anyone interested in knowledge-based news content. Subscribers get research results, feature pitches, breaking news and experts delivered directly to their email.
Register as a journalist or media relations professional

Newswise members are innovative, influential organizations world-wide, including top medical schools, universities, research institutions, public relations firms, government agencies, non-profit organizations, associations and advocacy groups.

Read more about Newswise

Find out about membership opportunities

Submission Deadline
 
1/28/10
Winter Sports
2/11/10
Diabetes: Awareness, Prevention and Treatment
2/18/10
Environmental Issues
2/25/10
Spring Season
3/4/10
Public Health, Infectious Disease, and Immunizations
3/11/10
Outer Space
3/18/10
Earth Day
4/1/10
Cancer Research
4/8/10
Asthma, Allergies and Clean Air
4/15/10
Environmental Issues
4/22/10
Pediatrics
4/29/10
Exercise/Physical Fitness/Sports